[ad_1] Shares of Sangamo Therapeutics Inc. fell 23% in very active trading on Wednesday morning after the company released the first results of a gene-editing trial for a rare metabolic disorder called …
Read More »Sangamo Therapeutics stock falls 23% on results of cutting-edge gene editing trial
